๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong flag Hong Kong ยท Delayed Price ยท Currency is HKD
0.9850
-0.0150 (-1.50%)
Nov 20, 2026, 3:59 PM HKT

HKG:0950 Financials Overview

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5381,4361,4001,0531,2331,266
Revenue Growth
7.08%2.57%32.95%-14.61%-2.61%4.06%
Gross Profit
816.96729.56753.36551.31770.76806.28
Operating Income
128.67110.28133.5536.04127.44-95.13
Net Income
119.7791.9493.116.751.281,987
Earnings Per Share
0.200.160.160.030.093.37
EPS Growth
30.23%-1.26%457.53%-67.44%-97.42%1434.25%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Licensed-In Products
630.39564.34553.24467.28733.34749.14
Proprietary and Generic Products
907.34871.65846.73585.76499.81517.02
Total
1,5381,4361,4001,0531,2331,266

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
364.39349.9216.85171189.3277.53
Total Debt
249.84310.27227.3204.14163.49267.14
Net Cash (Debt)
114.5539.63-10.45-33.1425.8110.39
Net Cash Growth
189.06%---148.36%-95.97%
Net Cash Per Share
0.190.07-0.02-0.060.040.02

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
383.15332.9242.01110.08283.63210.68
Capital Expenditures
-109.44-66.63-43.96-29.43-17.46-50.7
Free Cash Flow
273.71266.27198.0680.65266.18159.99
Free Cash Flow Growth
2.79%34.44%145.58%-69.70%66.37%98.70%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
53.13%50.81%53.81%52.35%62.50%63.68%
Operating Margin
8.37%7.68%9.54%3.42%10.33%-7.51%
Pretax Margin
6.42%5.08%7.01%2.92%5.50%155.54%
Profit Margin
7.79%6.40%6.65%1.59%4.16%156.94%
FCF Margin
17.80%18.54%14.15%7.66%21.58%12.64%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0450.0450.0450.0180.0200.061
Dividend Per Share Growth
23.40%0%150.00%-10.00%-67.21%5.17%
Dividend Yield
4.57%2.96%3.17%1.18%1.23%1.83%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
4.859.748.9853.9518.720.99
Forward PE
-8.468.4610.898.1510.41
P/FCF Ratio
2.123.364.2211.173.6112.26
PS Ratio
0.380.620.600.860.781.55